β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
about
Iron age: novel targets for iron overload.A Red Carpet for Iron Metabolism.Investigational drugs in phase I and phase II clinical trials for thalassemia.The heme exporter Flvcr1 regulates expansion and differentiation of committed erythroid progenitors by controlling intracellular heme accumulation.What can we learn from ineffective erythropoiesis in thalassemia?
P2860
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
@ast
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
@en
type
label
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
@ast
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
@en
prefLabel
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
@ast
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis.
@en
P2860
P1476
β-Thalassemia and Polycythemia vera: targeting chronic stress erythropoiesis
@en
P2093
Bart J Crielaard
Stefano Rivella
P2860
P356
10.1016/J.BIOCEL.2014.03.029
P577
2014-04-06T00:00:00Z